The outlook of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced substantial uncertainty . Investors are now grappling with the consequences of riv